Malinova Vesna, Schlegel Anna, Rohde Veit, Mielke Dorothee
Department of Neurosurgery, Georg-August-University, Robert-Koch-Straße 40, 37075, Göttingen, Germany.
Neurosurg Rev. 2017 Jul;40(3):397-402. doi: 10.1007/s10143-016-0792-x. Epub 2016 Oct 10.
For the fibrinolytic therapy of intracerebral hematomas (ICH) using recombinant tissue plasminogen activator (rtPA), a catheter position in the core of the hematoma along the largest clot diameter was assumed to be optimal for an effective clot lysis. However, it never had been proven that core position indeed enhances clot lysis if compared with less optimal catheter positions. In this study, the impact of the catheter position on the effectiveness and on the time course of clot lysis was evaluated. We analyzed the catheter position using a relative error calculating the distance perpendicular to the catheter's center in relation to hematoma's diameter and evaluated the relative hematoma volume reduction (RVR). The correlation of the RVR with the catheter position was evaluated. Additionally, we tried to identify patterns of clot lysis with different catheter positions. The patient's outcome at discharge was evaluated using the Glasgow outcome score. A total of 105 patients were included in the study. The mean hematoma volume was 56 ml. The overall RVR was 62.7 %. In 69 patients, a catheter position in the core of the clot was achieved. We found no significant correlation between catheter position and hematoma RVR (linear regression, p = 0.14). Core catheter position leads to more symmetrical hematoma RVR. Faster clot lysis happens in the vicinity of the catheter openings. We found no significant difference in the patient's outcome dependent on the catheter position (linear regression, p = 0.90). The catheter position in the core of the hematoma along its largest diameter does not significantly influence the effectiveness of clot lysis after rtPA application.
对于使用重组组织型纤溶酶原激活剂(rtPA)进行脑内血肿(ICH)的纤维蛋白溶解疗法,沿血肿最大凝块直径将导管置于血肿核心位置被认为是实现有效凝块溶解的最佳位置。然而,与不太理想的导管位置相比,核心位置确实能增强凝块溶解这一点从未得到证实。在本研究中,评估了导管位置对凝块溶解有效性和时间进程的影响。我们使用相对误差分析导管位置,该相对误差计算垂直于导管中心的距离与血肿直径的关系,并评估相对血肿体积减少量(RVR)。评估了RVR与导管位置的相关性。此外,我们试图识别不同导管位置的凝块溶解模式。使用格拉斯哥预后评分评估患者出院时的预后。共有105名患者纳入研究。平均血肿体积为56毫升。总体RVR为62.7%。69名患者实现了导管置于凝块核心位置。我们发现导管位置与血肿RVR之间无显著相关性(线性回归,p = 0.14)。核心导管位置导致血肿RVR更对称。在导管开口附近凝块溶解更快。我们发现患者预后在导管位置方面无显著差异(线性回归,p = 0.90)。沿血肿最大直径将导管置于血肿核心位置对rtPA应用后凝块溶解的有效性无显著影响。